SupplySide West Booths # 7427 and # 3318
Novozymes, the world leader in biological solutions, collaborates with customers, partners, and the global community to find biological answers to preserve the planet’s resources and help build better lives. Its human health growth platform, Novozymes OneHealth, delivers clinically proven supplements and consumer health products that will help people live healthier and better lives by Rethinking Tomorrow within human health.
Novozymes OneHealth’s core B2B brand, OneHealth, works with partners to create distinctive products with validated, targeted modes of action. Known as One-in-a-trillion biology-based solutions, each product has been developed in response to verifiable consumer needs and addresses a specific, profound health challenge related to modern lifestyles. All OneHealth products are supported by clinical studies and intellectual property protections.
At SupplySide West in booth 3318, Novozymes OneHealth will highlight its natural vitamin K2-7, MenaquinGold®. Ready to be formulated into various supplements for diverse health indications, MenaquinGold® is non-soy and non-synthetic, made possible through a chickpea-based, soy-free fermentation process. MenaquinGold® may support bone and heart health, and promising new science also shows benefits related to nerve and sports health. A recent Council of Responsible Nutrition (CRN) report emphasized the risk-reducing effect vitamin K2 supplementation could have on the occurrence of adverse heart-related events. The report found that in 2022 alone, if all US adults aged 55 or above had taken a vitamin K2 supplement, the net cost savings expected from reduced health care-attributed expenditures would have been $7.87 billion[1].
Novozymes OneHealth will showcase diverse products across brain, oral, and protective immune health at booth 7427. Teams will be available to discuss:
Pylopass™ Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri ) DSM 17648 – A postbiotic solution that may help to reduce the load of Helicobacter pylori in the stomach.
About 50% of the global population is affected by Helicobactor Pylori[2], a common bacterium that can cause gastric upset. This equates to around 4 billion people[3] who could benefit from support.
ProbioBrain™ Bifidobacterium longum 1714® – A probiotic solution for mental wellness
ProbioBrain™ with Bifidobacterium longum 1714® targets the gut-brain axis and has been shown in two placebo- controlled clinical trials to: Help adults handle the psychological and physical responses to everyday stress, help reduce cortisol output in response to everyday stress, and help to maintain a calm state of mind and emotional balance[4][5].
In 2021, global consumers rated mental wellbeing as the most significant criterion (64.1%) when it came to their perception of health[6]. Supplements for brain health in North America are a growing business opportunity estimated to be worth USD 4 billion by 2025, with an expected growth rate of 7.2%[7].
BioFresh™ 4+ – An enzymatic solution eliminating oral malodor for up to 4 hours
Self-perceived ‘bad breath’ affects as much as half of Americans surveyed and disturbs the intimacy of 70% of consumers surveyed – and their loved ones[8]. BioFresh™ 4+ contains a plant extract that binds bad breath-causing molecules and neutralizes them in a multistep reaction, without harming the oral microbiota[9]. The plant extract is activated by a natural enzyme that swiftly positions the plant extract to interact with and neutralize specific malodorous breath molecules.
Novozymes OneHealth will also introduce BioFresh™ Clean, a powerful new oral health solution that responds to consumers’ need for more efficient and convenient oral care solutions.
BioFresh™ Clean is a clinically proven enzyme combination that immediately removes and reduces oral biofilm for a cleaner and healthier oral cavity, while maintaining a healthy oral microbiome[10]. With advanced formatting options for on the go consumer products, BioFresh™ Clean supports consumers’ growing need to expand oral care routines using safe, natural, portable solutions, with or without abrasive support.
[1] CRN Foundation. Supplements to savings. Frost & Sullivan. 2022. https://www.crnusa.org/sites/default/files/HCCS/00-CRN-Supplements-to-Savings-2022-FullReport.pdf. Accessed August 31, 2022.
[2] Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2):420-429. doi:10.1053/j.gastro.2017.04.022
[3] Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2):420-429. doi:10.1053/j.gastro.2017.04.022
[4] Allen A, Hutch W, Borre Y et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry. 2016;6(11):e939-e939. doi:10.1038/tp.2016.191
[5] Wang H, Braun C, Murphy EF, Enck P. Bifidobacterium longum 1714™ Strain Modulates Brain Activity of Healthy Volunteers During Social Stress. Am J Gastroenterol. 2019;114(7):1152-1162. doi:10.14309/ajg.0000000000000203
[6] Euromonitor International Voice of the Consumer: Health and Nutrition Survey, fielded Feb 2021, n= 21,460
[7] Grand View Research, Coherent Market Insight
[8] Novozymes OneHealth proprietary consumer insights study 2019
[9] Novozymes OneHealth Internal Report 2019: BioFresh4+ Oral microbiome pilot test
[10] Two Novozymes OneHealth proprietary randomized, placebo-controlled clinical trials: Trial 1: Prevention on biofilm build-up, 2020. Trial 2: Removal of established biofilm, 2020.
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
